A multicenter phase II study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancer (Q37225701)

From Wikidata
Jump to navigation Jump to search
scientific article published on 12 May 2009
edit
Language Label Description Also known as
English
A multicenter phase II study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancer
scientific article published on 12 May 2009

    Statements

    A multicenter phase II study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancer (English)
    M Andreuccetti

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit